By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amplyx Pharmaceuticals 

1505 Chestnut Street

San Francisco  California    U.S.A.
Phone: 415-578-3263 Fax: n/a




Company News
San Diego's Amplyx Names A New CEO 1/6/2017 7:42:40 AM
Amplyx Appoints Ciara Kennedy, Ph.D., As President And Chief Executive Officer 1/5/2017 7:46:45 AM
FDA Grants Orphan Drug Designation To Amplyx For APX001 For Treatment Of Multiple Invasive Fungal And Mold Infections 11/16/2016 11:03:38 AM
Amplyx Initiates Dosing In Phase 1 Clinical Trial Of APX001, A Novel Antifungal Product Candidate For Treatment Of Life-Threatening Infections 9/12/2016 6:21:35 AM
Amplyx Announces Qualified Infectious Disease Product Designation For APX001 In Three Life-threatening Fungal Infections 6/15/2016 10:18:17 AM
Amplyx Appoints Paul C. Grint, M.D., To Board Of Directors 5/24/2016 6:42:01 AM
SoCal's Amplyx Ups Series B Financing to $49.2 Million and Beefs Up Executive Team 2/9/2016 6:11:14 AM
San Diego’s Amplyx Bags $41 Million to Fight a Deadly Fungus 11/11/2015 6:26:49 AM
Amplyx Pharmaceuticals Announces Completion And Extension Of Series A Preferred 4/8/2010 8:58:13 AM
With VC Money Scarce, Biotech Startup Amplyx Pharmaceuticals Gets Angel Funding 1/15/2009 7:41:19 AM